862549-37-9

Upstream product

• 213828-29-6 1-(benzyloxy)-2-[(4-methoxyphenoxy)methyl]-4-penten-2-ol 
• 213828-28-5 1-(benzyloxy)-3-(4-methoxyphenoxy)acetone 
• 98696-20-9 1-benzyloxy-3-(4-methoxy-phenoxy)-propan-2-ol 
• 213828-30-9 5-[(4-methoxyphenoxy)methyl]-5-[(phenylmethoxy)methyl]-3,4,5-trihydrofuran-2-one 

Downstream Products

• 1219016-54-2 C₁₈H₂₄O₅ 
• 862549-45-9 (E)-5,5-bis[(phenylmethoxy)methyl]-3-[5-methyl-3-(2-methylpropyl)hexylidene]-4,5-dihydrofuran-2-thione 
• 862549-43-7 (Z)-5,5-bis[(phenylmethoxy)methyl]-3-[5-methyl-3-(2-methylpropyl)hexylidene]-4,5-dihydrofuran-2-one 
• 862549-41-5 (E)-5,5-bis[(phenylmethoxy)methyl]-3-[5-methyl-3-(2-methylpropyl)hexylidene]-4,5-dihydrofuran-2-one 
• 862549-39-1 5,5-bis[(phenylmethoxy)methyl]-3,4,5-trihydrofuran-2-one 

Relevant academic research and scientific papers

Polar 3-alkylidene-5-pivaloyloxymethyl-5′-hydroxymethyl-γ-lactones as protein kinase C ligands and antitumor agents

A series of DAG-lactones with polar 3-alkylidene substituents have been investigated as PKC-α ligands and antitumor agents. Extensive analysis of structure-activity relationships for the 3-alkylidene chain revealed that polar groups such as ether, hydroxy

GLYCEROL COMPOUNDS AND METHODS OF USE

Provided herein, inter alia, are compounds of fatty acid glycerol derivatives and compositions including the same.

DIACYLGLYCEROL LACTONE COMPOUND, PREPARATION METHOD THEREFOR, AND IMMUNOSTIMULATOR CONTAINING SAME AS ACTIVE INGREDIENT

Disclosed are a novel diacylglycerol lactone compound for improving immunity and inhibiting infection by promoting neutrophil movement, a preparation method therefor, and an immunostimulator containing same as an active ingredient. The diacyloglycerol lactone compound is represented by chemical formula 1 of the specification. In chemical formula 1, R1 and R2 are respectively N and independently a C2-30 fatty acid group.

Conformationally constrained analogues of diacylglycerol (DAG). 25. Exploration of the sn-1 and sn-2 carbonyl functionality reveals the essential role of the sn-1 carbonyl at the lipid interface in the binding of DAG-lactones to protein kinase C

Diacylglycerol (DAG) lactones with altered functionality (C=O → CH2 or C=O → C=S) at the sn-1 and sn-2 carbonyl pharmacophores were synthesized and used as probes to dissect the individual role of each carbonyl in the binding to protein kinase